Bio101 has an extensive industry network and significant industry experience
Bio101: Powering the growth of healthcare businesses.
Since 2016, we’ve provided our clients with financial advisory and governance support.
Bio101 was established in 2016 with a view that there was an opportunity to provide a focused finance, company secretarial and transaction advisory service to the biotech and healthcare sector. Bio101 has had strong growth since 2016 with; three (3) executive directors, one (1) non-executive director (Chair) and approximately thirty-five (35) staff across three (3) states and two (2) countries.
Our growth has been driven by our strong reputation.
Growth has been primarily organic, driven by the growing biotech and healthcare sector and word-of-mouth referrals. We have approximately 100 clients who are a mix of ASX listed, venture capital investee, companies seeking to list on the ASX, spin outs from universities and research institutes along with offshore entities establishing an Australian presence for the favourable clinical trial conditions and potential access to the R&D tax incentive.
We are starting to get noticed
Our continued growth has started to draw attention. A recent Accuity Magazine Feature Article expands on our story and explains the simple formula driving our expansion READ HERE.
Continuing to deliver.
Today, we have three key divisions – Finance, CoSec & Transaction Advisory – all of which form a complementary relationship in helping our client’s needs. At its heart we are about providing clients with financial advisory and governance support – thereby allowing our clients to focus on their R&D and business priorities.
